Cell injury and premature neurodegeneration in focal malformations of cortical development

Brain Pathology

Volumn 24, Issue 1, 2014, Pages 1-17

  Iyer, Anand ^a   Prabowo, Avanita ^a   Anink, Jasper ^a   Spliet, Wim G M ^b   Van Rijen, Peter C ^c   Aronica, Eleonora ^a,d,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

apoptosis; cortical tubers; epilepsy; focal cortical dysplasia; mTOR; neurodegeneration

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CASPASE 3; CASPASE 6; CYTOKINE RECEPTOR; DEATH RECEPTOR 6; DNA NUCLEOTIDYLEXOTRANSFERASE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P62; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BALLOON CELL; CELL TYPE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; FEMALE; GIANT CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NERVE CELL LESION; NERVE DEGENERATION; NICK END LABELING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

APOPTOSIS; CORTICAL TUBERS; EPILEPSY; FOCAL CORTICAL DYSPLASIA; MTOR; NEURODEGENERATION;

ADOLESCENT; ADULT; APOPTOSIS; EPILEPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MIDDLE AGED; NEURONS; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 84890796647     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12060     Document Type: Article

References (69)

1. An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, et al (2003) Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am J Pathol 163: 591-607. (Pubitemid 36909421)
2. Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Ramkema M, Troost D, (2003) Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in Taylor-type focal cortical dysplasia. Epilepsia 44: 785-795. (Pubitemid 36754003)
3. Aronica E, Gorter JA, Redeker S, Ramkema M, Spliet WG, van Rijen PC, et al (2005) Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropath Appl Neurobiol 31: 280-291. (Pubitemid 40769527)
4. Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G, 2nd, et al (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56: 478-487. (Pubitemid 39319337)
5. Ben-Ari Y, (2008) Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders. Trends Neurosci 31: 626-636.
6. Benschop R, Wei T, Na S, (2009) Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6. Adv Exp Med Biol 647: 186-194.
7. Bhardwaj A, Aggarwal BB, (2003) Receptor-mediated choreography of life and death. J Clin Immunol 23: 317-332. (Pubitemid 37083187)
8. Blumcke I, Spreafico R, (2011) An international consensus classification for focal cortical dysplasias. Lancet Neurol 10: 26-27.
9. Blümcke I, Vinters HV, Armstrong D, Aronica E, Thom M, Spreafico R, (2009) Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Dis 11: 181-193.
10. Blurton-Jones M, Laferla FM, (2006) Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res 3: 437-448. (Pubitemid 46066423)
11. Boer K, Troost D, Timmermans W, Gorter JA, Spliet WG, Nellist M, et al (2008) Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Neuroscience 156: 203-215.
12. Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WG, et al (2010) Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol 20: 704-719.
13. Boer K, Troost D, Timmermans W, van Rijen PC, Spliet WG, Aronica E, (2010) Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors. Brain Pathol 20: 234-244.
14. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA, (2004) Molecular pathways to neurodegeneration. Nat Med 10 (Suppl.): S2-S9. (Pubitemid 38901861)
15. Bothwell M, Giniger E, (2000) Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 102: 271-273.
16. Caccamo A, Majumder S, Deng JJ, Bai Y, Thornton FB, Oddo S, (2009) Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem 284: 27416-27424.
17. Cai Z, Zhao B, Li K, Zhang L, Li C, Quazi SH, Tan Y, (2012) Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease? J Neurosci Res 90: 1105-1118.
18. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB, (2012) Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 72: 881-992.
19. Choi J, Nordli DR, Jr, Alden TD, DiPatri A, Jr, Laux L, Kelley K, et al (2009) Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 6: 38.
20. Crino PB, (2011) mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 17: 734-742.
21. D'Amelio M, Cavallucci V, Cecconi F, (2010) Neuronal caspase-3 signaling: not only cell death. Cell Death Differ 17: 1104-1114.
22. Dickey CA, Koren J, Zhang YJ, Xu YF, Jinwal UK, Birnbaum MJ, et al (2008) AKT and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci U S A 105: 3622-3627. (Pubitemid 351723602)
23. Engel JJ, (1993) Outcome with respect to epileptic seizures. In: Surgical Treatment of the Epilepsies, JJ Engel, (ed.), pp. 609-621. Raven Press: New York.
24. Gomez M, Sampson J, Whittemore V, (1999) The Tuberous Sclerosis Complex. Oxford University Press: Oxford.
25. Guo Q, Li H, Gaddam SS, Justice NJ, Robertson CS, Zheng H, (2012) Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives. J Biol Chem 287: 2437-2445.
26. Ichimura Y, Komatsu M, (2010) Selective degradation of p62 by autophagy. Semin Immunopathol 32: 431-436.
27. Inoue H, Matsushige T, Hasegawa S, Abe A, Iida Y, Inoue T, Ichiyama T, (2012) Elevation of tau protein levels in the cerebrospinal fluid of children with West syndrome. Epilepsy Res 102: 8-12.
28. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, Aronica E, (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51: 1763-1773.
29. Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, et al (2010) Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Neuroscience 167: 929-945.
30. Jefferson T, Causevic M, auf dem Keller U, Schilling O, Isbert S, Geyer R, et al (2011) Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem 286: 27741-27750.
31. Katewa SD, Kapahi P, (2011) Role of TOR signaling in aging and related biological processes in Drosophila melanogaster. Exp Gerontol 46: 382-390.
32. Komatsu M, Ichimura Y, (2010) Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 584: 1374-1378.
33. Komatsu M, Kageyama S, Ichimura Y, (2012) p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 66: 457-462.
34. Kuester M, Kemmerzehl S, Dahms SO, Roeser D, Than ME, (2011) The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP). J Mol Biol 409: 189-201.
35. Laplante M, Sabatini DM, (2012) mTOR signaling in growth control and disease. Cell 149: 274-293.
36. Li HY, Yeh PA, Chiu HC, Tang CY, Tu BP, (2011) Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation. PLoS ONE 6: e23075.
37. Li X, Alafuzoff I, Soininen H, Winblad B, Pei JJ, (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J 272: 4211-4220. (Pubitemid 41160927)
38. Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, Swann JW, et al (2006) Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 60: 420-429. (Pubitemid 44684978)
39. Maldonado M, Baybis M, Newman D, Kolson DL, Chen W, McKhann GN, et al (2003) Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis 14: 279-290. (Pubitemid 37311291)
40. Martinian L, Boer K, Middeldorp J, Hol EM, Sisodiya SM, Squier W, et al (2009) Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies. Neuropathol Appl Neurobiol 35: 394-405.
41. Mi S, Lee X, Hu Y, Ji B, Shao Z, Yang W, et al (2011) Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat Med 17: 816-821.
42. Nguyen MD, Mushynski WE, Julien JP, (2002) Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ 9: 1294-1306. (Pubitemid 36097699)
43. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M, (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457: 981-989.
44. Oddo S, (2012) The role of mTOR signaling in Alzheimer disease. Front Biosci 4: 941-952.
45. Orlova KA, Tsai V, Baybis M, Heuer GG, Sisodiya S, Thom M, et al (2010) Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol 69: 850-863.
46. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, et al (2004) Terminology and classification of the cortical dysplasias. Neurology 62 (6 Suppl. 3): S2-S8. (Pubitemid 38419835)
47. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, et al (1998) Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431: 351-356. (Pubitemid 28352389)
48. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH, (1999) Conversion of p35 to p25 deregulates CDK5 activity and promotes neurodegeneration. Nature 402: 615-622. (Pubitemid 129516324)
49. Ponomarev SY, Audie J, (2011) Computational prediction and analysis of the DR6-NAPP interaction. Proteins 79: 1376-1395.
50. Rusten TE, Simonsen A, (2008) ESCRT functions in autophagy and associated disease. Cell Cycle 7: 1166-1172. (Pubitemid 351749268)
51. Sarnat HB, Flores-Sarnat L, Crino P, Hader W, Bello-Espinosa L, (2012) Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis. Folia Neuropathologica 50: 330-345.
52. Schick V, Majores M, Koch A, Elger CE, Schramm J, Urbach H, Becker AJ, (2007) Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions. Epilepsia 48 (Suppl. 5): 65-73. (Pubitemid 47512204)
53. Sen A, Thom M, Martinian L, Harding B, Cross JH, Nikolic M, Sisodiya SM, (2007) Pathological tau tangles localize to focal cortical dysplasia in older patients. Epilepsia 48: 1447-1454. (Pubitemid 47245800)
54. Sephton CF, Cenik B, Cenik BK, Herz J, Yu G, (2012) TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration. Biol Chem 393: 589-594.
55. Sisodiya SM, Thom M, Lin WR, Bajaj NP, Cross JH, Harding BN, (2002) Abnormal expression of CDK5 in focal cortical dysplasia in humans. Neurosci Lett 328: 217-220. (Pubitemid 34876650)
56. Spangle JM, Munger K, (2010) The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 84: 9398-9407.
57. Tam SJ, Richmond DL, Kaminker JS, Modrusan Z, Martin-McNulty B, Cao TC, et al (2012) Death receptors DR6 and TROY regulate brain vascular development. Dev Cell 22: 403-417.
58. Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM, (2005) Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol 110: 383-392. (Pubitemid 41672183)
59. Thom M, Liu JY, Thompson P, Phadke R, Narkiewicz M, Martinian L, et al (2011) Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study. Brain 134 (Pt 10): 2969-2981.
60. Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WG, et al (2009) Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia 50: 1409-1418.
61. van der Loos CM, (2008) Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 56: 313-328. (Pubitemid 351429800)
62. van Veelen CW, Debets RM, van Huffelen AC, de Boas W, Binnie CD, Storm van Leeuwen W, et al (1990) Combined use of subdural and intracerebral electrodes in preoperative evaluation of epilepsy. Neurosurgery 26: 93-101. (Pubitemid 20209545)
63. Vohra BP, Sasaki Y, Miller BR, Chang J, DiAntonio A, Milbrandt J, (2010) Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J Neurosci 30: 13729-13738.
64. Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ, Shen CK, (2012) Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A 109: 15024-15029.
65. Wang IF, Tsai KJ, Shen CK, (2012) Autophagy activation ameliorates neuronal pathogenesis of FTLD-U mice: a new light for treatment of TARDBP/TDP-43 proteinopathies. Autophagy 9: 239-240.
66. Westmark CJ, Westmark PR, Beard AM, Hildebrandt SM, Malter JS, (2008) Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. Int J Clin Exp Pathol 1: 157-168.
67. Westmark CJ, Westmark PR, Malter JS, (2010) Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures. J Alzheimers Dis 20: 1009-1013.
68. Zeng L, Li T, Xu DC, Liu J, Mao G, Cui MZ, et al (2012) Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with bax protein. J Biol Chem 287: 29125-29133.
69. Zhou X, Ikenoue T, Chen X, Li L, Inoki K, Guan KL, (2009) Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy. Proc Natl Acad Sci U S A 106: 8923-8928.